KMBKimberly-Clark

$110.32

The financials

Kimberly-Clark by the numbers

Kimberly-Clark (KMB) reported revenue of $4.19B in Q2 2026 (quarter ended June 30, 2026), up 0.6% from the same quarter a year earlier. That came with a gross margin of 38% and net income of $345M (8.2% of revenue). For the full year FY2025, revenue was $16.4B (−2.1% year on year) and net income $2.02B. Its largest product in 2026-Q1 was Babyandchildcareproducts at $1.70B, 41% of the disclosed total, just ahead of Family Care at 25%.

Kimberly-Clark income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$4.19B$4.16B+0.6%
Gross profit$1.60B$1.46B+10%
Operating income$633M$592M+6.9%
Net income$345M$509M−32%
Diluted EPS$1.04$1.53−32%
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Babyandchildcareproducts$1.70B41%
Family Care$1.04B25%
Adult Care Products$483M12%
Professional Products$460M11%
Feminine Care Products$451M11%
All Other$33M0.8%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $4.16B (+0.31%)
All Other grew +32% year on yearFamily Care +1.3% year on year
  • Babyandchildcareproducts$1.70BQoQ +0.65%year on year +3.6%
  • Family Care$1.04BQoQ -year on year +1.3%
  • Adult Care Products$483.0MQoQ -1.4%year on year +1.5%
  • Professional Products$460.0MQoQ -3.0%year on year +3.1%
  • Feminine Care Products$451.0MQoQ +4.6%year on year +1.8%
  • All Other$33.0MQoQ -2.9%year on year +32%
  • Consumer Tissue Products-QoQ -year on year -
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-04-28, SEC EDGAR